Human Carcinoembryonic Antigen (CEA) Protein

2223€ (500 µg)
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
Human Carcinoembryonic Antigen (CEA) Protein
category
Proteins and Peptides
provider
Abbexa
reference
abx060976
tested applications
ELISA
Description
Human Carcinoembryonic Antigen (CEA) Protein (Antigen Grade) is a Human protein isolated from Human Metastatic Liver. It can be used for antisera production, as a tracer for iodination and as a standard for immunoassays.
Documents del producto
Instrucciones
Data sheet
Product specifications
Category | Proteins and Peptides |
Immunogen Target | Carcinoembryonic Antigen (CEA) |
Host | Human |
Recommended Dilution | Optimal dilutions/concentrations should be determined by the end user. |
Origin | Human |
Conjugation | Unconjugated |
Observed MW | Concentration: 6.4 mg/ml |
Expression | Native |
Purity | Shows multiple protein bands at 150-210 kDa on SDS-PAGE denaturing. |
Purification | Immunoaffinity purification. |
Size 1 | 500 µg |
Form | Liquid |
Tested Applications | ELISA |
Buffer | 0.1 M PBS, pH 7.4, containing 2% methyl-mannoside and 0.9% NaN3. |
Availability | Shipped within 10-20 working days. |
Storage | Aliquot and store at -20 °C. Avoid repeated freeze/thaw cycles. |
Dry Ice | No |
Background | Protein CEA |
Status | RUO |
Note | This product is for research use only. Not for human consumption, cosmetic, therapeutic or diagnostic use. |
Descripción
Related Products

Rat CEA (Carcinoembryonic Antigen) ELISA Kit
Ver Producto
Rat CEA (Carcinoembryonic Antigen) QuickTest ELISA Kit
Ver Producto
Carcinoembryonic Antigen (CEACAM5) Antibody
Carcino Embryonic Antigen (CEA) is synthesised during development in the fetal gut, and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. Antibodies to CEA are useful in identifying the origin of various metastatic adenocarcinomas and in distinguishing pulmonary adenocarcinomas (60 to 70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+).
Ver Producto